Extracellular vesicles derived from mesenchymal stem cells: A platform that can be engineered.

Bo Qin, Qí Zhāng, Dan Chen, Hai Yu, Ai Luo, Liang peng Suo, Yan Cai, De yang Cai, Jia Luo, Ju Huang, Kun XiongPubMed 2021 · DOI

Abstract

Mesenchymal stem cells play an important role in tissue damage and repair. This role is mainly due to a paracrine mechanism, and extracellular vesicles (EVs) are an important part of the paracrine function. EVs play a vital role in many aspects of cell homeostasis, physiology, and pathology, and EVs can be used as clinical biomarkers, vaccines, or drug delivery vehicles. A large number of studies have shown that EVs derived from mesenchymal stem cells (MSC-EVs) play an important role in the treatment of various diseases. However, the problems of low production, low retention rate, and poor targeting of MSC-EVs are obstacles to current clinical applications. The engineering transformation of MSC-EVs can make up for those shortcomings, thereby improving treatment efficiency. This review summarizes the latest research progress of MSC-EV direct and indirect engineering transformation from the aspects of improving MSC-EV retention rate, yield, targeting, and MSC-EV visualization research, and proposes some feasible MSC-EV engineering methods of transformation.
BibTeX
@inproceedings{qin2021extracellular,
  author = {Bo Qin and Qí Zhāng and Dan Chen and Hai Yu and Ai Luo and Liang peng Suo and Yan Cai and De yang Cai and Jia Luo and Ju Huang and Kun Xiong},
  title = {{Extracellular vesicles derived from mesenchymal stem cells: A platform that can be engineered.}},
  booktitle = {PubMed},
  year = {2021},
  doi = {10.14670/hh-18-297},
}

Loading related content...

Figure